Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This phase II trial studies the long-term side effects of ruxolitinib in treating patients with myelofibrosis. Collecting data about the long-term safety and tolerability of ruxolitinib may better help future patients with myelofibrosis.
Epistemonikos ID: f741c9b8b2e19b2b1baa93d5d792f7dd60f9ca01
First added on: May 13, 2024